Search

everythinglearnresearchcommunity

for

Search:↓

Oxidative stress worsens PCOS by damaging cells and disrupting metabolism, suggesting antioxidant treatments might help.

The 2023 guideline advises a detailed approach for PCOS, focusing on early detection, lifestyle and medical treatments, and managing health risks.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

The conclusion is that proper diagnosis and long-term treatment, including medication, hair removal, and lifestyle changes, are important for improving hirsutism, especially in PCOS patients.

Adult female acne is complex and requires a combination of treatments for effective management.

The most common skin problems in perimenopausal women in South India are infections, eczemas, and acne, possibly worsened by external factors and lifestyle practices.

Polycystic ovary syndrome and iron overload share similar symptoms and can be potentially treated with blood removal, diet changes, and probiotics.

Most women with PCOS have insulin resistance, especially those with phenotype B.

The study found that PCOS affects about 6.5-6.8% of women in both urban and rural areas of Telangana, India, and highlighted the importance of lifestyle changes for management.

Different types of PCOS need specific diagnosis methods and treatments.

Genes and epigenetic changes are important in the development of Polycystic Ovary Syndrome.

Polycystic Ovary Syndrome (PCOS) affects 6%-15% of women of reproductive age, causing symptoms like acne and hair loss, and increasing the risk of type 2 diabetes and heart disease; it's managed through diet, exercise, and medications like Metformin and hormonal contraceptives.

Some epilepsy drugs can cause reproductive and cosmetic side effects in women and affect pregnancy, but most women still have healthy babies.

Some blood-thinning medications can increase the risk of bleeding, and certain factors like genetics and other health conditions affect their safety and effectiveness.

New antiscarring strategies show promise, including drugs, stem cells, and improved surgical techniques.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

Finasteride boosts morphine's pain relief, stops tolerance, and reduces withdrawal in rats.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

Hair loss and aging are caused by the breakdown of a key protein in hair stem cells.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Blocking JAK-STAT signaling can lead to hair growth.

Finasteride reduces male rat fertility by causing issues with copulatory plug formation.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Higher enzyme levels found in women with hair loss, suggesting hormone imbalance.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

HIV patients with lower CD4 T cell counts often have more skin problems.

Hair follicle samples effectively show how well the drug MK-0752 targets and engages with the Notch pathway.

The effects of estrogen on human scalp hair growth are unclear and need more research.